Comparative Study Between ICSI Results in Transvaginal Ultrasound Guided Embryo Transfer and Transabdominal Ultrasound Guided Embryo Transfer
Launched by CAIRO UNIVERSITY · Sep 24, 2018
Trial Information
Current as of May 29, 2025
Unknown status
Keywords
ClinConnect Summary
One hundred and twenty patients were randomly allocated to either the trans-abdominal guided embryo transfer group (n= 60) or the transvaginal guided embryo tranfer group ( n = 60) . The investigators used a computer generated randomization table obtained from http://graphpad. com/quickcalcs/randomize1 and sequentially numbered sealed opaque envelopes to randomize the patients to the study groups. The allocation information was written on a card placed in the sealed envelopes. A colleague (who was not directly involved in the study) prepared the randomization table and the sealed envelopes....
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Infertile female patients aged 20-37 years old undergoing IVF
- • Long protocol
- • Embryo transfer of fresh cycles D3
- Exclusion Criteria:
- • Uterine abnormalities e.g. sub-mucous fibroid, or fibroids indenting the endometrium, polyps, Ashermann, etc.
- • Poor responders
- • Female patients ˃35 years old
- • Medical disorders e.g. DM, HTN
- • Immunological disorders e.g. SLE, APS
- • Cervical distortions
- • Thyroid or adrenal dysfunction
- • Endometriosis grade 3 or 4
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Ahmed maged, MD
Principal Investigator
Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials